Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Authors: van Loenhout, C.J., van der Leest, C.H., Becker-Commissaris, A., Borgers, J.S.W., Terhegggen, F., van den Borne, B.E.E.M., van Warmerdam, L.J.C., van Leeuwen, L., van der Meer, F.S., Tiemessen, M.A., van Diepen, D.M., Klaver, Y., Hamberg, A.P., Libourel, E.J., Strobbe, L., Cloos, M., Geraedts, E.J., Drooger, J.C., Heller, R., de Groot, J.W.B., Stigt, J.A., Nuij, V.J.A.A., Pitz, C.C.M., Slingerland, M., Borm, F.J., Haberkorn, B.C.M., Westeinde, S.C. van 't, Aarts, M.J.B., van Putten, J.W.G., Youssef, M., Cirkel, G.A., Herder, G.J.M., van Rooijen, C.R., Citgez, E., Barlo, N.P., Scholtes, B.M.J., Koornstra, R.H.T., Claessens, N.J.M., Faber, L.M., Rikers, C.H., van de Wetering, R.A.W., Veurink, G.L., Bouter, B.W., Houtenbos, I., Bard, M.P.L., Herbschleb, K.H., Kastelijn, E.A., Brocken, P., Douma, G., Jalving, M., Hiltermann, T.J.N., Schuurbiers-Siebers, O.C.J., Suijkerbuijk, K.P.M., van Lindert, A.S.R., van de Wouw, A.J., van den Boogaart, V.E.M., Bakker, S.D., Looysen, E., Peerdeman, A.L., de Jong, W.K., Siemerink, E.J.M., Staal, A.J., Franken, B., van Geffen, W.H., Bootsma, G.P., de Joode, Karlijn, Dumoulin, Daphne W., Tol, Jolien, Westgeest, Hans M., Beerepoot, Laurens V., van den Berkmortel, Franchette W.P.J., Mutsaers, Pim G.N.J., van Diemen, Nico G.J., Visser, Otto J., Oomen-de Hoop, Esther, Bloemendal, Haiko J., van Laarhoven, Hanneke W.M., Hendriks, Lizza E.L., Haanen, John B.A.G., de Vries, Elisabeth G.E., Dingemans, Anne-Marie C., van der Veldt, Astrid A.M.

Source: In European Journal of Cancer December 2020 141:171-184

31P The IOpener study: Tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer

Authors: Joode, K.D., Groen, H.J.M., van den Heuvel, M., Kloover, J.S., van der Meer, F., Stigt, J.A., van der Leest, C.H., Van Den Borne, B., de Wijn, R., Hurkmans, D.P., van den Heuvel, D.M.A., van Doorn, T., Pinedo, B., Kapiteijn, E., Debets, R., Verdegaal, E., van der Burg, S.H., Groten, J.P., Aerts, J.G., Mathijssen, R.H.

Source: In Immuno-Oncology and Technology December 2022 16 Supplement 1

1335P The relationship between nivolumab pharmacokinetics and cancer cachexia biomarkers in patients with metastatic non-small cell lung cancer (NSCLC)

Authors: Hofman, M., Agema, B.C., Degens, J., Hurkmans, D.P., Dumoulin, D.W., Schols, A., Koolen, S.L., Groeneveldt, C., Worp, W.V.D., Hendriks, L.E., Van Der Leest, C.H., Aerts, J.G., Mathijssen, R.H., Dingemans, A-M.C., Langen, R., Bins, S.

Source: In Annals of Oncology September 2024 35 Supplement 2:S847-S847

1540P - Influence of cow’s milk on the absorption and exposure of erlotinib in NSCLC patients

Authors: Veerman, G.D.M. ¹, Hussaarts, K G A M ¹, Peric, R. ², Oomen-de Hoop, E. ¹, Landa, K. ¹, Van Der Leest, C.H. ³, Broerse, S.D. ⁴, Rutten, H.B. ⁵, Paats, M.S. ², van Gelder, T. ⁶, Koolen, S.L. ¹, Aerts, J.G. ⁷, van Leeuwen, R.W. ⁶, Mathijssen, R.H. ¹

Source: In Annals of Oncology October 2019 30 Supplement 5:v632-v632

1274P - A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients

Authors: Hurkmans, D.P. ¹, Basak, E.A. ², van Dijk, T. ², Mercieca, D. ³, Schreurs, M.W.J. ⁴, Wijkhuijs, A.J.M. ⁴, Bins, S. ⁵, Oomen-de Hoop, E. ⁶, Debets, R. ², Joerger, M. ⁷, Odink, A. ⁸, Van der Veldt, A.A.M. ⁹, Van Der Leest, C.H. ¹⁰, Aerts, J.G. ¹¹, Mathijssen, R.H.J. ⁶, Koolen, S.L. ¹²

Source: In Annals of Oncology October 2019 30 Supplement 5:v518-v518